A review of the use of Next Generation Sequencing methodologies to identify biomarkers of resistance to CKK4/6 inhibitors in ER+/HER2-breast cancer
Servetto, A., et al. A review of the use of Next Generation Sequencing methodologies to identify biomarkers of resistance to CKK4/6 inhibitors in ER+/HER2-breast cancer. Science Direct December 2020 DEC 9, 103191
- Categories
- Peer Reviewed Publications
- Reviews